Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • Medication Access During Natural Disasters
  • Suicide Prevention
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Requirements
  • Medication Access During Natural Disasters
  • Suicide Prevention
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Oct 17 2022

Full Issue

Cancer Vaccine Possible By 2030, BioNTech Co-Founders Say

BioNTech's Uğur Şahin and Özlem Türeci say mRNA technology at the heart of their company’s covid vaccine could be repurposed so that it primed the immune system to attack cancer cells instead of invading coronaviruses, The Guardian reports. Plus, the latest efforts to eradicate polio worldwide.

Press Association: Cancer Vaccine Could Be Available By 2030, Say Scientists Behind Covid Shot

Cancer vaccines could be accessible to patients within the next decade, the husband and wife team behind one of the most successful Covid jabs has said. German couple Professors Ugur Sahin and Ozlem Tureci said they are hesitant to say they can find a cure for cancer, but that they have had "breakthroughs" they will keep working on. (10/16)

The Guardian: Vaccines To Treat Cancer Possible By 2030, Say BioNTech Founders 

Uğur Şahin and Özlem Türeci, who co-founded BioNTech, the German firm that partnered with Pfizer to manufacture a revolutionary mRNA Covid vaccine, said they had made breakthroughs that fuelled their optimism for cancer vaccines in the coming years. Speaking on the BBC’s Sunday with Laura Kuenssberg, Prof Türeci described how the mRNA technology at the heart of BioNTech’s Covid vaccine could be repurposed so that it primed the immune system to attack cancer cells instead of invading coronaviruses. (Sample, 10/16)

In updates on the effort to eradicate polio —

AP: Gates Foundation Pledges $1.2B To Eradicate Polio Globally 

The Bill and Melinda Gates Foundation says it will commit $1.2 billion to the effort to end polio worldwide. The money will be used to help implement the Global Polio Eradication Initiative’s strategy through 2026. The initiative is trying to end the polio virus in Pakistan and Afghanistan, the last two endemic countries, the foundation said in a statement Sunday. The money also will be used to stop outbreaks of new variants of the virus. The announcement was made Sunday at the World Health Summit in Berlin. (10/16)

Bloomberg: Gates Pledges $1.2 Billion To Speed End Of Crippling Poliovirus

Bill Gates says polio came tantalizingly close to being eradicated in the spring, before new outbreaks were seeded in Africa and a man was paralyzed in New York. Now the billionaire’s philanthropic foundation is pledging $1.2 billion to complete the mission. (Gale, 10/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF